Campbell & Co Investment Adviser’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.64M Buy
21,872
+18,376
+526% +$3.61M 0.24% 94
2026
Q1
$685K Sell
3,496
-12,402
-78% -$2.41M 0.04% 639
2025
Q4
$2.76M Buy
15,898
+10,609
+201% +$1.93M 0.13% 237
2025
Q3
$1.01M Buy
+5,289
New +$939K 0.08% 416
2025
Q2
Sell
-5,110
Closed -$865K 1199
2025
Q1
$865K Sell
5,110
-309
-6% -$50.8K 0.07% 483
2024
Q4
$818K Sell
5,419
-5,758
-52% -$896K 0.06% 473
2024
Q3
$1.74M Sell
11,177
-6,734
-38% -$1.01M 0.13% 231
2024
Q2
$2.45M Buy
+17,911
New +$2.45M 0.21% 118
2023
Q2
Sell
-4,239
Closed -$600K 941
2023
Q1
$600K Buy
4,239
+1,446
+52% +$207K 0.11% 343
2022
Q4
$437K Buy
+2,793
New +$401K 0.1% 376
2021
Q3
Sell
-1,864
Closed -$246K 626
2021
Q2
$246K Buy
+1,864
New +$244K 0.1% 382
2021
Q1
Sell
-5,914
Closed -$705K 464
2020
Q4
$705K Buy
+5,914
New +$721K 0.43% 39
2018
Q2
Sell
-2,570
Closed -$258K 410
2018
Q1
$258K Buy
+2,570
New +$263K 0.22% 210
2017
Q4
Sell
-3,059
Closed -$286K 421
2017
Q3
$286K Buy
3,059
+1,025
+50% +$109K 0.23% 174
2017
Q2
$226K Buy
+2,034
New +$215K 0.21% 222
2014
Q1
Sell
-12,900
Closed -$691K 223
2013
Q4
$691K Buy
+12,900
New +$765K 0.16% 146

Other funds holding DGX

Campbell & Co Investment Adviser's DGX Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Quest Diagnostics (DGX) stake by 526% in Q2 2026, buying an estimated $3.61M and bringing the position to 21,872 shares worth $4.64M. The position accounts for 0.24% of the portfolio, ranked #94.

Campbell & Co Investment Adviser first reported a position in DGX in Q4 2013 and has held it in 16 quarters since. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Campbell & Co Investment Adviser held 21,872 shares of Quest Diagnostics worth $4.64M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 18,376 Quest Diagnostics shares in Q2 2026, an estimated $3.61M.
  • Quest Diagnostics made up 0.24% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #94 holding.
  • Campbell & Co Investment Adviser first reported a position in Quest Diagnostics in Q4 2013 and has held it in 16 quarters since.
  • 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.